These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of helicobacter-induced carcinogenesis. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, Murphy JC. Infect Immun; 1996 May; 64(5):1548-58. PubMed ID: 8613359 [Abstract] [Full Text] [Related]
4. Epidermal growth factor and transforming growth factor-alpha-associated overexpression of cyclin D1, Cdk4, and c-Myc during hepatocarcinogenesis in Helicobacter hepaticus-infected A/JCr mice. Ramljak D, Jones AB, Diwan BA, Perantoni AO, Hochadel JF, Anderson LM. Cancer Res; 1998 Aug 15; 58(16):3590-7. PubMed ID: 9721866 [Abstract] [Full Text] [Related]
5. Impact of Helicobacter hepaticus infection in B6C3F1 mice from twelve National Toxicology Program two-year carcinogenesis studies. Hailey JR, Haseman JK, Bucher JR, Radovsky AE, Malarkey DE, Miller RT, Nyska A, Maronpot RR. Toxicol Pathol; 1998 Aug 15; 26(5):602-11. PubMed ID: 9789946 [Abstract] [Full Text] [Related]
6. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Whary MT, Cline J, King A, Ge Z, Shen Z, Sheppard B, Fox JG. Comp Med; 2001 Oct 15; 51(5):413-7. PubMed ID: 11924800 [Abstract] [Full Text] [Related]
7. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Rogers AB, Boutin SR, Whary MT, Sundina N, Ge Z, Cormier K, Fox JG. Toxicol Pathol; 2004 Oct 15; 32(6):668-77. PubMed ID: 15513910 [Abstract] [Full Text] [Related]
8. Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus-infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks. García A, Ihrig MM, Fry RC, Feng Y, Xu S, Boutin SR, Rogers AB, Muthupalani S, Samson LD, Fox JG. Infect Immun; 2008 May 15; 76(5):1866-76. PubMed ID: 18285497 [Abstract] [Full Text] [Related]
9. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ, Gorelick PL, Nagashima K, Gonda MA, Gilden RV. J Natl Cancer Inst; 1994 Aug 17; 86(16):1222-7. PubMed ID: 8040890 [Abstract] [Full Text] [Related]
10. Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Sipowicz MA, Weghorst CM, Shiao YH, Buzard GS, Calvert RJ, Anver MR, Anderson LM, Rice JM. Carcinogenesis; 1997 Jan 17; 18(1):233-6. PubMed ID: 9054612 [Abstract] [Full Text] [Related]
11. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Ihrig M, Schrenzel MD, Fox JG. Am J Pathol; 1999 Aug 17; 155(2):571-82. PubMed ID: 10433949 [Abstract] [Full Text] [Related]
12. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Ward JM, Benveniste RE, Fox CH, Battles JK, Gonda MA, Tully JG. Am J Pathol; 1996 Feb 17; 148(2):509-17. PubMed ID: 8579113 [Abstract] [Full Text] [Related]
13. Liver tumorigenesis by Helicobacter hepaticus: considerations of mechanism. Canella KA, Diwan BA, Gorelick PL, Donovan PJ, Sipowicz MA, Kasprzak KS, Weghorst CM, Snyderwine EG, Davis CD, Keefer LK, Kyrtopoulos SA, Hecht SS, Wang M, Anderson LM, Rice JM. In Vivo; 1996 Feb 17; 10(3):285-92. PubMed ID: 8797029 [Abstract] [Full Text] [Related]
14. Alteration in cell kinetics in control B6C3F1 mice infected with Helicobacter hepaticus. Nyska A, Maronpot RR, Eldridge SR, Haseman JK, Hailey JR. Toxicol Pathol; 1997 Feb 17; 25(6):591-6. PubMed ID: 9437804 [Abstract] [Full Text] [Related]
15. Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure. Diwan BA, Sipowicz M, Logsdon D, Gorelick P, Anver MR, Kasprzak KS, Anderson LM. Environ Health Perspect; 2008 Oct 17; 116(10):1352-6. PubMed ID: 18941577 [Abstract] [Full Text] [Related]
16. Hepatic temporal gene expression profiling in Helicobacter hepaticus-infected A/JCr mice. Boutin SR, Rogers AB, Shen Z, Fry RC, Love JA, Nambiar PR, Suerbaum S, Fox JG. Toxicol Pathol; 2004 Oct 17; 32(6):678-93. PubMed ID: 15513911 [Abstract] [Full Text] [Related]
17. Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Fox JG, Yan L, Shames B, Campbell J, Murphy JC, Li X. Infect Immun; 1996 Sep 17; 64(9):3673-81. PubMed ID: 8751916 [Abstract] [Full Text] [Related]
18. Sex influence on chronic intestinal inflammation in Helicobacter hepaticus-infected A/JCr mice. Livingston RS, Myles MH, Livingston BA, Criley JM, Franklin CL. Comp Med; 2004 Jun 17; 54(3):301-8. PubMed ID: 15253277 [Abstract] [Full Text] [Related]
19. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Li X, Fox JG, Whary MT, Yan L, Shames B, Zhao Z. Infect Immun; 1998 Nov 17; 66(11):5477-84. PubMed ID: 9784560 [Abstract] [Full Text] [Related]
20. Comparison of methods of identifying Helicobacter hepaticus in B6C3F1 mice used in a carcinogenesis bioassay. Fox JG, MacGregor JA, Shen Z, Li X, Lewis R, Dangler CA. J Clin Microbiol; 1998 May 17; 36(5):1382-7. PubMed ID: 9574710 [Abstract] [Full Text] [Related] Page: [Next] [New Search]